Tumor Budding is a Valuable Diagnostic Parameter in Prediction of Disease Progression of Endometrial Endometrioid Carcinoma
Authors:
- 2 January 2019
- journal article
- research article
- Published by Springer Nature in Pathology and Oncology Research
- Vol. 25 (2) , 723-730
Abstract
Recently, tumor budding (TB) found at the invasive margin has been related to lymph node involvement (LNI), local recurrence, and poor prognosis in various cancers. We assessed the presence of TB in endometrial endometrioid carcinoma (EEC), and examined the immunohistochemical (IHC) profiles to define its clinicopathological significance. Ninety-six EECs were obtained from 2008 to 2013. During the follow-up, ten patients experienced disease progression; of these, three patients succumbed to the disease. All hematoxylin and eosin-stained slides were scrutinized for the presence of TB. IHC stainings for estrogen receptor (ER), progesterone receptor (PR), β-catenin, and E-cadherin were performed. All cases were grouped as FIGO grade (G) 1 (47.9%), G2 (29.2%), and G3 (22.9%). The distribution for depth of invasion (DOI) was 68.5% with a DOI of less than half and 31.5% with a DOI of more than half. Myometrial invasion was characterized as infiltrating pattern (52.1%), adenomyosis-like (20.8%), microcystic, elongated, and fragmented (17.7%), or expansile (9.4%). TB was identified in 63 cases (65.6%). Lymphovascular invasion (LVI) and LNI were identified in 47 and 37 cases, respectively. TB was associated with deep DOI (p = 0.001), higher FIGO grade (p = 0.006), LVI (p < 0.0001), and LNI (p < 0.0001). TB showed loss of ER (p < 0.0001) and PR (p < 0.0001), reduced E-cadherin (p < 0.0001) expression, and aberrant β-catenin expression (p = 0.042). In EECs, TB was associated with deep DOI, less-differentiated histology, frequent LVI, and LNI; furthermore, TB was closely related to epithelial-mesenchymal transition phenotype and downregulation of hormonal receptors. Therefore, TB might be a determinant histologic clue for prediction of disease progression in EECs.Keywords
Funding Information
- National Research Foundation of Korea (NRF-2017R1D1A1B03036519)
This publication has 20 references indexed in Scilit:
- Patterns of Myoinvasion in Endometrial AdenocarcinomaAdvances in Anatomic Pathology, 2013
- Clinicopathological Risk Factors for Pelvic Lymph Node Metastasis in Clinical Early-Stage Endometrioid Endometrial AdenocarcinomaInternational Journal of Gynecological Cancer, 2012
- The EMT signaling pathways in endometrial carcinomaClinical and Translational Oncology, 2012
- Tumor budding and E-Cadherin expression in endometrial carcinoma: Are they prognostic factors in endometrial cancer?Gynecologic Oncology, 2012
- Progesterone Inhibits Epithelial-to-Mesenchymal Transition in Endometrial CancerPLOS ONE, 2012
- Trop-2 Overexpression in Poorly Differentiated Endometrial Endometrioid CarcinomaInternational Journal of Gynecological Cancer, 2011
- Tumor budding as a prognostic marker in laryngeal carcinomaPathology - Research and Practice, 2010
- Immunophenotypic features of MELF pattern invasion in endometrial adenocarcinoma: evidence for epithelial–mesenchymal transitionHistopathology, 2009
- Tumour budding at invasive margins and outcome in colorectal cancerColorectal Disease, 2007
- Tumor budding as a useful prognostic marker in esophageal squamous cell carcinomaDiseases of the Esophagus, 2004